School-age outcomes of newborns treated for persistent pulmonary hypertension

Journal of Perinatology

Volumn 30, Issue 2, 2010, Pages 127-134

  Rosenberg, A A ^a   Lee, N R ^a   Vaver, K N ^a   Werner, D ^a   Fashaw, L ^a   Hale, K ^a   Waas, N ^a  

^a Children's Hospital Colorado   (United States)

Author keywords

Inhaled nitric oxide; Persistent pulmonary hypertension of the newborn; School age outcome

Indexed keywords

NITRIC OXIDE;

ACADEMIC ACHIEVEMENT; ACUTE RESPIRATORY FAILURE; ADAPTIVE BEHAVIOR; ANAMNESIS; ARTICLE; CHILD; CHILD BEHAVIOR CHECKLIST; CHILD GROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; ECHOCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; FOLLOW UP; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; NEWBORN; OUTCOME ASSESSMENT; PERCEPTION DEAFNESS; PERSISTENT PULMONARY HYPERTENSION; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PSYCHOMETRY; SCHOOL CHILD; SENSORIMOTOR FUNCTION; SOCIAL INTERACTION; THORAX RADIOGRAPHY; WECHSLER INTELLIGENCE SCALE; WISCONSIN CARD SORTING TEST;

CHILD; CHILD BEHAVIOR DISORDERS; CHILD, PRESCHOOL; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; INFANT, NEWBORN; LONGITUDINAL LIGAMENTS; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; PROSPECTIVE STUDIES; RESPIRATORY THERAPY; TREATMENT OUTCOME; WECHSLER SCALES;

EID: 76449107544     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2009.139     Document Type: Article

References (36)

1. Kinsella JP, Neish S, Shaffer E, Abman SH. Low dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 819-820.
2. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in PPHN. Lancet 1992; 340: 818-819.
3. Roberts JD, Fineman JR, Morin III FC, Shaul PW, Rimar S, Schreiber MD et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 1997; 336: 605-610.
4. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 1997; 131: 55-62.
5. Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double masked, placebo-controlled, dose-response, multicenter study. Pediatrics 1998; 101: 325-334. (Pubitemid 28136402)
6. Kennaugh JM, Kinsella JP, Abman SH, Hernandez JA, Moreland SG, Rosenberg AA. Impact of new treatments for neonatal pulmonary hypertension on extracorporeal membrane oxygenation use and outcome. J Perinatol 1997; 17: 366-369.
7. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 2000; 342: 469-474.
8. Christou H, VanMarter LJ, Wessel DL, Allred EN, Kane JW, Thompson JE et al. Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn. Crit Care Med 2000; 28: 3722-3727.
9. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 2003; 349: 2099-2107.
10. Van Meurs KP, Wright LL, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK et al. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med 2005; 353: 13-22.
11. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 2006; 355: 343-353.
12. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 2006; 355: 354-364.
13. Barrington KJ, Finer NN. Inhaled nitric oxide for preterm infants: a systematic review. Pediatrics 2007; 120: 1088-1099.
14. Rosenberg AA, Kennaugh JM, Moreland SG, Fashaw LM, Hale KA, Torielli FM et al. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J Pediatr 1997; 131: 70-75.
15. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in term and nearterm infants: neurodevelopmental follow-up of the Neonatal Inhaled Nitric Oxide Study Group (NINOS). J Pediatr 2000; 136: 611-617.
16. Lipkin PH, Davidson D, Spivak L, Straube A, Rhines J, Chang CT et al. Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide. J Pediatr 2002; 140: 306-310.
17. Konduri GG, Vohr B, Robertson C, Sokol GM, Solimano A, Singer J et al. Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up. J Pediatr 2007; 150: 235-240.
18. Ellington Jr M, O'Reilly D, Allred EN, McCormick MC, Wessel DL, Kourembanas S. Child health status, neurodevelopmental outcome, and parental satisfaction in a randomized, controlled trial of nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 2001; 107: 1351-1356.
19. McNally H, Bennett CC, Elbourne D, Field DJ, UK Collaborative ECMO Trial Group. United Kingdom collaborative randomized trial of neonatal extracorporeal membrane oxygenation: follow-up to age 7 years. Pediatrics 2006; 117: e845-e854. (Pubitemid 46071351)
20. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr 1993; 123: 103-108.
21. Wechsler D. Wechsler Preschool and Primary Scale of Intelligence-Revised. The Psychological Corporation: San Antonio, TX, 1989.
22. Wechsler D. Wechsler Intelligence Scale for Children, 3rd edn. The Psychological Corporation: San Antonio, TX, 1991.
23. Sparrow SS, Balla DA, Cicchetti DV. Vineland Adaptive Behavior Scales-Interview Edition Survey Form. American Guidance Service: Circle Pines, MN, 1984.
24. Kaufman AS, Kaufman NL. Kaufman Test of Educational Achievement. American Guidance Service: Circle Pines, MN, 1985.
25. Boll T. Children's Category Test. The Psychological Corporation: San Antonio, TX, 1993.
26. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G. Manual for the Wisconsin Card Sorting Test. Psychological Assessment Resources: Odessa, FL, 1993.
27. Achenbach TM. Manual for the Child Behavior Checklist for Ages 4-18. University of Vermont, Department of Psychiatry: Burlington, VT, 1991.
28. Achenbach TM. Teacher's Report Form for Ages 5-18. University of Vermont, Department of Psychiatry: Burlington, VT, 1991.
29. Vaucher YE, Dudell GG, Bejar R, Gist K. Predictors of early childhood outcome in candidates for extracorporeal membrane oxygenation. J Pediatr 1996; 128: 109-117
30. Wildin SR, Landry SH, Zwischenberger JB. Prospective, controlled study of developmental outcome in survivors of extracorporeal membrane oxygenation: the first 24 months. Pediatrics 1994; 93: 404-408.
31. Glass P, Wagner AE, Papero PH, Rajasingham SR, Civetello LA, Kjaer MS et al. Neurodevelopmental status at age five years of neonates treated with extracorporeal membrane oxygenation. J Pediatr 1995; 127: 447-457.
32. Hofkosh D, Thompson AE, Nozza RJ, Kemp SS, Bowen A, Feldman HM. Ten years of extracorporeal membrane oxygenation: neurodevelopmental outcome. Pediatrics 1991; 87: 549-555.
33. Hendricks-Munoz KD, Walton JP. Hearing loss in infants with persistent fetal circulation. Pediatrics 1988; 81: 650-656.
34. Marron M-J, Crisafi MA, Driscoll Jr JM, Wung JT, Driscoll YT, Fav TH et al. Hearing and neurodevelopmental outcome in survivors of persistent pulmonary hypertension of the newborn. Pediatrics 1992; 90: 392-396.
35. Hamutcu R, Nield TA, Garg M, Keens TJ, Platzker AC. Long-term pulmonary sequelae in children who were treated with extracorporeal membrane oxygenation for neonatal respiratory failure. Pediatrics 2004; 114: 1292-1296.
36. Torielli F, Fashaw LM, Knudsen O, Kinsella J, Ivy D, Valdes-Cruz L et al. Echocardiographic outcome of infants treated as newborns with inhaled nitric oxide for severe hypoxemic respiratory failure. J Pediatr 2001; 138: 349-354.